Centessa Pharmaceuticals, a wholly owned subsidiary of Eli C. Lilly and Company, is a clinical-stage company focused on developing orexin receptor 2 (OX2R) agonists for sleep-wake disorders like narcolepsy. The company's lead candidate, cleminorexton, is in development for narcolepsy types 1 and 2, and idiopathic hypersomnia. Centessa also has other clinical and preclinical assets targeting neurological, neurodegenerative, and neuropsychiatric conditions. Headquartered in Boston, Massachusetts, Centessa was recognized as a Great Place to Work® in 2026. This role is a temporary position with the potential to convert to a permanent role, responsible for day-to-day trial management, coordinating internal cross-functional teams and overseeing CROs and external vendors to ensure studies are delivered on time, within budget, and in compliance with quality and regulatory standards. This role requires hands-on involvement in clinical trial execution, proactive identification and resolution of operational issues, and accountability for study performance metrics and deliverable quality. The CTM also contributes to operational planning, risk assessment, and continuous process improvement in collaboration with study team leadership.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Career Level
Mid Level